Who will succeed Gottlieb at FDA?

FDA Commissioner Dr. Scott Gottlieb said this week he will be stepping away from his position in one month, leaving one major question – who will take replace him? While it’s impossible to know who will be appointed, a number of candidates stand out for the role, while others seem less likely but still viable candidates to head the agency. Topping the list of likely candidates is former Flatiron Health chief medical officer and current principal deputy commissioner Amy Abernethy, who stands as a likely interim leader, according to a report from STAT News. Abernethy reportedly spent time at Duke with former FDA Commissioner Robert Califf acting as a mentor, according to the report, but her lack of tenure at the FDA – she joined in December – could reduce the likelihood she’ll win an appointment at the head of the federal watchdog. Current National Cancer Institute director Ned Sharpless, who co-founded G1 Therapeutics and previously ran the University of North Carolina’s Lineberger Comprehensive Cancer Center, could be a likely pick for the position, according to STAT. Sharpless co-founded two clinical-stage biotech and was an enthusiastic supporter of Gottlieb’s efforts related to tobacco and e-cigarettes. Current Dept. of Health and Human Services assistant secretary for health Bret Giroir’s experience in the government, academia and the industry position him as a possible candidate for the job, according to STAT. He has led the majority of the HH...
Source: Mass Device - Category: Medical Devices Authors: Tags: Featured Food & Drug Administration (FDA) Source Type: news